Sensorion
1 known investors
Sensorion is a French clinical-stage biopharmaceutical company founded in 2009 in Montpellier that develops gene-therapy and small-molecule treatments for inner-ear disorders like genetic deafness and tinnitus.
Investors · 1
In the news
Frequently asked questions
- What does Sensorion do?
- Sensorion is a French clinical-stage biopharmaceutical company founded in 2009 in Montpellier that develops gene-therapy and small-molecule treatments for inner-ear disorders like genetic deafness and tinnitus.
- Who are Sensorion's investors?
- Sensorion's investors include Sofinnova Partners.